Samina S Khan approaches inspections with a meticulous attention to detail, focusing on the integrity of production processes, documentation compliance, and the effectiveness of quality control measures. She exhibits a thorough approach to root cause analysis and expects comprehensive corrective and preventive actions for identified non-conformities. Furthermore, she highlights the importance of equipment and facility validation in ensuring compliance with regulatory standards.

Samina S Khan is a detail-oriented FDA investigator who places a strong emphasis on process control, documentation management, root cause analysis, and quality control procedures. She is thorough in scrutinizing the integrity of production processes, adherence to standard operational procedures, and the effectiveness of corrective and preventive actions. Additionally, she is likely to prioritize the validation of equipment and facility management practices during inspections.